Geloca, Lilibeth T.

HRN: 29-27-94  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2026
METRONIDAZOLE 500MG (TAB)
07/11/2026
07/17/2026
ORAL
500 Mg
TID
AGE
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines